Size fractionation of bacterial capsular polysaccharides for their use in conjugate vaccines
- 12 February 1999
- Vol. 17 (9-10) , 1251-1263
- https://doi.org/10.1016/s0264-410x(98)00348-x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and CVaccine, 1992
- Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infantsThe Journal of Pediatrics, 1992
- Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccinesThe Journal of Pediatrics, 1992
- Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugates.Journal of Clinical Investigation, 1992
- IMMUNOGENICITY IN INFANTS OF HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE IN A CONJUGATE VACCINE WITH NEISSERIA MENINGITIDIS OUTER-MEMBRANE PROTEINThe Lancet, 1986
- Immunogens consisting of oligosaccharides from the capsule of Haemophilus influenzae type b coupled to diphtheria toxoid or the toxin protein CRM197.Journal of Clinical Investigation, 1985
- ANTIBODY LEVELS ACHIEVED IN INFANTS BY COURSE OF HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE/DIPHTHERIA TOXOID CONJUGATE VACCINEThe Lancet, 1985
- Abbreviated Terminology of Oligosaccharide ChainsEuropean Journal of Biochemistry, 1982
- Structures of the Capsular Polysaccharides of Neisseria meningitidis as Determined by 13C-Nuclear Magnetic Resonance SpectroscopyThe Journal of Infectious Diseases, 1977
- Quantitive estimation of sialic acidsBiochimica et Biophysica Acta, 1957